BIOMAT Database Logo BIOMAT Database Logo

[Effect of the central nervous system on therapy of experimental meningeal tuberculosis in dogs]. 1955

N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA

UI MeSH Term Description Entries
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit
D014390 Tuberculosis, Meningeal A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. (From Adams et al., Principles of Neurology, 6th ed, pp717-9) Meningitis, Tuberculous,TB Meningitis,Tubercular Meningitis,Tuberculosis Meningitis,Tuberculous Hypertrophic Pachymeningitis,Hypertrophic Pachymeningitides, Tuberculous,Hypertrophic Pachymeningitis, Tuberculous,Meningeal Tuberculoses,Meningeal Tuberculosis,Meningitides, Tubercular,Meningitides, Tuberculosis,Meningitides, Tuberculous,Meningitis, Tubercular,Meningitis, Tuberculosis,Pachymeningitides, Tuberculous Hypertrophic,Pachymeningitis, Tuberculous Hypertrophic,TB Meningitides,Tubercular Meningitides,Tuberculoses, Meningeal,Tuberculosis Meningitides,Tuberculous Hypertrophic Pachymeningitides,Tuberculous Meningitides,Tuberculous Meningitis

Related Publications

N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
[Meningeal central nervous system tuberculosis in children].
January 2005, Problemy tuberkuleza i boleznei legkikh,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
Experimental tuberculosis of the central nervous system.
June 1970, Neurology India,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
[Therapy of tuberculosis of the central nervous system].
January 1954, Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
[Electroencephalographic study of functional state of central nervous system in meningeal tuberculosis patients].
January 1957, Problemy tuberkuleza,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
Meningeal Lymphatics in Central Nervous System Diseases.
April 2024, Annual review of neuroscience,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
[Pathomorphology of the central nervous system in experimental atherosclerosis in dogs].
January 1962, Arkhiv patologii,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
[Experimental tuberculosis in dogs with various types of the nervous system].
January 1954, Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
[Central nervous system tuberculosis: diagnosis and therapy].
December 1998, Nihon rinsho. Japanese journal of clinical medicine,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
[Endocrine disorders in meningeal tuberculosis: Cushing syndrome with disseminated central nervous system changes].
January 1958, Neurologia, neurochirurgia i psychiatria polska,
N MUNTIU, and E MIRZA, and F PREDOVICIU, and F NEREANTIU, and P BEGNESCU, and V ZAHARIA
Experimental hyperphenylalaninemia: effect on central nervous system myelin subfractions.
February 1980, Experimental neurology,
Copied contents to your clipboard!